top of page

           COVID-19 (Coronavirus) Test Kit (AccuQuik™)

Capture d’écran 2020-03-18 à 10.11.23.

ONLY 15 MINUTES FOR RESULTS !

PRODUCT INFORMATION

 

AccuQuik COVID-19 IgG/IgM test kit is a lateral flow immunoassay for the simultaneous detection and differentiation of IgG anti-COVID-19 virus and IgM anti-COVID-19 virus in human whole blood, serum, or plasma. It is intended to be used by the professionals as a screening test and as an aid in the diagnosis of infection with COVID-19 viruses (SARS-CoV-2).

Coronaviruses are enveloped RNA viruses that are distributed broadly among humans, other mammals, and birds and that cause respiratory, enteric, hepatic, and neurological diseases. Six coronavirus species are known to cause human diseases. Four viruses – 229E, OC43, NL63, and HKU1 – are prevalent and typically cause common cold symptoms in immunocompetent individuals. The two other strains — severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) — are zoonotic in origin and have been linked to sometimes fatal illness. Given the high prevalence and wide distribution of coronaviruses, the large genetic diversity and frequent recombination of their genomes, and increasing human–animal interface activities, novel coronaviruses are likely to emerge periodically in humans owing to frequent cross-species infections and occasional spillover events.

          AccuQuik™ COVID-19 Test Kit             

AccuQuik COVID-19 test kit detects IgG and IgM anti-COVID-19 virus in one test within 15 minutes. The test is user friendly, without cumbersome laboratory equipment, and requires minimal staff trainings.

COVID-19 IgG/IgM Rapid Test Device (Whole Blood/Serum/Plasma) is a qualitative membrane-based immunoassay for the detection of COVID-19 antibodies in whole blood, serum, or plasma. This test consists of two components, an IgG component and an IgM component. In the test region, anti-human IgM and IgG is coated. During testing, the specimen reacts with COVID-19 antigen-coated particles in the test strip. The mixture then migrates upward on the membrane chromatographically by capillary action and reacts with the anti-human IgM or IgG in test line region. If the specimen contains IgM or IgG antibodies to COVID-19, a colored line will appear in test line region.

Therefore, if the specimen contains COVID-19 IgM antibodies, a colored line will appear in test line region M. If the specimen contains COVID-19 IgG antibodies, a colored line will appear in test line region G. If the specimen does not contain COVID-19 antibodies, no colored line will appear in either of the test line regions, indicating a negative result. To serve as a procedural control, a colored line will always appeared in the control line region, indicating that the proper volume of specimen has been added and membrane wicking has occurred.

       

                         

AVAILABLE FOR IMMEDIATE SHIPMENT

ADDITIONAL INFORMATION

IgG and IgM are the first antibodies appearing in the human immune system during infection. Because of their high specificity, when detecting acute COVID-19 infection, IgG and IgM antibodies have the advanages of high sensitivity, early diagnosis, and the ability to judge wheather a suspect is infected.

IgG and IgM antibodies can only be produced after several days of viral infection and differ between individuals.

Capture d’écran 2020-03-18 à 13.35.25.

APPLICATION SCENARIOS

Who can use this kit ?

Banner and Pic-v03-02.jpg

   MEDIQUEST VENTURE LLC

60, Chemin des BOULANGERS

     1294 - Genthod/GENEVA

               SWITZERLAND

                   Call

   T: +41 79 616 56 24

   MEDIQUEST VENTURE LLC

    30N Gould Street  - Ste R

      SHERIDAN  WY  82801

                      U.S.A

                   Call

   T: +1 310 227 6242

Capture d’écran 2024-01-23 à 17.02.34.png

 2016-2024 by ThD.

                     Contact

tdindeleux@medi-quest.com

bottom of page